BlackRock’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1M | Sell |
|
|||||
|
2024
Q2 | $1.98M | Sell |
|
|||||
|
2024
Q1 | $4.7M | Sell |
|
|||||
|
2023
Q4 | $5.15M | Buy |
|
|||||
|
2023
Q3 | $14M | Sell |
|
|||||
|
2023
Q2 | $19.6M | Sell |
|
|||||
|
2023
Q1 | $53.2M | Buy |
|
|||||
|
2022
Q4 | $54.8M | Buy |
|
|||||
|
2022
Q3 | $49.2M | Sell |
|
|||||
|
2022
Q2 | $86.1M | Sell |
|
|||||
|
2022
Q1 | $98.1M | Buy |
|
|||||
|
2021
Q4 | $100M | Sell |
|
|||||
|
2021
Q3 | $114M | Sell |
|
|||||
|
2021
Q2 | $89.1M | Buy |
|
|||||
|
2021
Q1 | $82.7M | Buy |
|
|||||
|
2020
Q4 | $90.4M | Buy |
|
|||||
|
2020
Q3 | $81M | Buy |
|
|||||
|
2020
Q2 | $83M | Buy |
|
|||||
|
2020
Q1 | $76.9M | Sell |
|
|||||
|
2019
Q4 | $109M | Buy |
|
|||||
|
2019
Q3 | $97.6M | Sell |
|
|||||
|
2019
Q2 | $97.1M | Buy |
|
|||||
|
2019
Q1 | $83.8M | Sell |
|
|||||
|
2018
Q4 | $69.7M | Sell |
|
|||||
|
2018
Q3 | $121M | Buy |
|
|||||
|
2018
Q2 | $108M | Buy |
|
|||||
|
2018
Q1 | $65.8M | Buy |
|
|||||
|
2017
Q4 | $65.8M | Sell |
|
|||||
|
2017
Q3 | $75.2M | Buy |
|
|||||
|
2017
Q2 | $94.6M | Sell |
|
|||||
|
2017
Q1 | $100M | Buy |
|
|||||
|
2016
Q4 | $52K | Sell |
|
|||||
|
2016
Q3 | $54K | Buy |
|
|||||
|
2016
Q2 | $28K | Buy |
|
|||||
|
2016
Q1 | $21K | Buy |
|
|||||
|
2015
Q4 | $17K | Hold |
|
|||||
|
2015
Q3 | $14K | Sell |
|
|||||
|
2015
Q2 | $183K | Buy |
|